Canopy Growth Corporation - Common Shares (CGC)
1.7400
+0.6100 (53.98%)
NASDAQ · Last Trade: Dec 12th, 4:54 PM EST
Detailed Quote
| Previous Close | 1.130 |
|---|---|
| Open | 1.380 |
| Bid | 1.700 |
| Ask | 1.710 |
| Day's Range | 1.330 - 1.790 |
| 52 Week Range | 0.7700 - 3.500 |
| Volume | 158,276,416 |
| Market Cap | 1.02B |
| PE Ratio (TTM) | -0.6192 |
| EPS (TTM) | -2.8 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 20,439,255 |
Chart
About Canopy Growth Corporation - Common Shares (CGC)
Canopy Growth Corp is a leading player in the cannabis industry, focusing on the production and distribution of a wide range of cannabis products. The company is engaged in cultivating and processing cannabis for both medical and recreational purposes, offering various forms such as dried flower, oils, edibles, and beverages. With a commitment to innovation, Canopy Growth invests in research and development to create high-quality products that meet consumer demands and adhere to evolving regulations. The company also emphasizes sustainability and responsible business practices, aiming to shape the future of cannabis consumption and enhance the overall experience for consumers. Read More
News & Press Releases
Scienjoy Holding Corporation (NASDAQ: SJ) is entering a potential inflection point following the commercial launch of AI Vista Live!, its next-generation digital human and mixed-reality AI performer platform now live in Dubai. The launch represents a critical transition in Scienjoy’s AI roadmap— moving its digital human strategy from vision to revenue —as the company begins scaling enterprise deployments and monetization across high-growth global markets.
Via AB Newswire · December 12, 2025
Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
Via Chartmill · December 12, 2025
President Trump wants to change the regulations on cannabis. Will this change Canopy into a profitable stock?
Via The Motley Fool · December 12, 2025
Discover the most active stocks in Friday's session. Stay informed about the stocks that are generating the most trading volume!
Via Chartmill · December 12, 2025
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · December 12, 2025
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via Chartmill · December 12, 2025
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced the national launch of Claybourne Gassers, a new lineup of All-in-One (AIO) vapes featuring liquid diamonds. The launch marks Claybourne’s entry into Canada’s vape category, building on its leadership in high potency infused products.
By Canopy Growth Corporation · Via Business Wire · December 4, 2025
Rigetti's November plunge erased October's gains and then some. Is the quantum computing stock a buy in this sudden dip?
Via The Motley Fool · December 3, 2025
420 with CNW — How the Hemp Industry Could Be Impacted by the Federal Ban on Hemp THC
A surge in hemp-derived THC products that reshaped convenience store shelves and fueled a fast-growing market appears to be heading toward a sharp slowdown. Tucked inside the bill that brought an end to the recent federal shutdown is a clause that would outlaw hemp-derived THC products nationwide.
Via CannabisNewsWire · December 3, 2025
420 with CNW — How the Hemp Industry Could Be Impacted by the Federal Ban on Hemp THC
A surge in hemp-derived THC products that reshaped convenience store shelves and fueled a fast-growing market appears to be heading toward a sharp slowdown. Tucked inside the bill that brought an end to the recent federal shutdown is a clause that would outlaw hemp-derived THC products nationwide.
Via Investor Brand Network · December 3, 2025
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has expanded its Spectrum Therapeutics portfolio in Australia with the availability of new softgel capsules, further enhancing the Company’s medical cannabis offerings in the region.
By Canopy Growth · Via Business Wire · November 18, 2025
420 with CNW — Michigan Files Defense in Case Challenging its New Marijuana Taxes
The state of Michigan is standing by its newly approved wholesale cannabis tax, stating that the measure complies with the state constitution and does not violate the 2018 ballot initiative that legalized recreational marijuana.
Via Investor Brand Network · November 17, 2025
420 with CNW — Michigan Files Defense in Case Challenging its New Marijuana Taxes
The state of Michigan is standing by its newly approved wholesale cannabis tax, stating that the measure complies with the state constitution and does not violate the 2018 ballot initiative that legalized recreational marijuana.
Via CannabisNewsWire · November 17, 2025
The U.S. government funding bill to end the shutdown included language tightening rules on hemp-derived THC products.
Via Stocktwits · November 13, 2025
Via Benzinga · November 11, 2025
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (Nasdaq: CGC) today announced its financial results for the second quarter ended September 30, 2025 ("Q2 FY2026"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.
By Canopy Growth Corporation · Via Business Wire · November 7, 2025
Tilray Brands (NASDAQ: TLRY) has once again found itself at the epicenter of market volatility, with its stock experiencing a significant dip this past week, closing near $1.34 USD as of early November 2025. This downturn comes amidst a complex tapestry of mixed signals, leaving investors and analysts grappling
Via MarketMinute · November 1, 2025
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.
Via Benzinga · November 3, 2025
420 with CNW — 39 State AGs Ask Congress to Ban Hemp-Sourced THC Products
A coalition of 39 attorneys general from 37 U.S. states and two territories is urging Congress to take immediate action against the growing sale of hemp-derived THC products. In a letter sent on October 24 to leaders of key Senate and House committees, the group called for a revision of federal law to close what they describe as a loophole in the Farm Bill 2018 that has allowed synthetic, psychoactive products to proliferate nationwide.
Via Investor Brand Network · October 31, 2025
420 with CNW — 39 State AGs Ask Congress to Ban Hemp-Sourced THC Products
A coalition of 39 attorneys general from 37 U.S. states and two territories is urging Congress to take immediate action against the growing sale of hemp-derived THC products. In a letter sent on October 24 to leaders of key Senate and House committees, the group called for a revision of federal law to close what they describe as a loophole in the Farm Bill 2018 that has allowed synthetic, psychoactive products to proliferate nationwide.
Via CannabisNewsWire · October 31, 2025
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2026 ended September 30, 2025 before financial markets open on November 7, 2025.
By Canopy Growth Corporation · Via Business Wire · October 24, 2025
420 with CNW — Study Uncovers Genetic Links Between Marijuana Use and Health Challenges
Researchers from the University of California San Diego School of Medicine, working alongside the genetics company 23andMe, have pinpointed specific regions in the human genome that appear to influence marijuana use .
Via CannabisNewsWire · October 17, 2025
420 with CNW — Study Uncovers Genetic Links Between Marijuana Use and Health Challenges
Researchers from the University of California San Diego School of Medicine, working alongside the genetics company 23andMe, have pinpointed specific regions in the human genome that appear to influence marijuana use .
Via Investor Brand Network · October 17, 2025
